Loading…
Reported covered position: Health Policy Director, Senate HELP CommitteeHealth Policy Advisor, Sen. Michael Enzi
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Training Tomorrow's Doctors Today Act
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENZYME via PODESTA GROUP, INC.
2014 · first_quarter · Q1
Patient Protection and Affordable Care Act and FDASIA (implementation). FDA policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via PODESTA GROUP, INC.
2014 · first_quarter · 1T
Source: Senate LDA
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE |
| 14 |
| 2010–2014 |
| AMERICAN CHEMISTRY COUNCIL | 13 | 2011–2013 |
| COVIDIEN | 13 | 2010–2013 |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 12 | 2011–2014 |
| VIROPHARMA INCORPORATED | 11 | 2011–2014 |
| WAL-MART | 10 | 2010–2012 |
| CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) | 9 | 2012–2014 |
| KINDRED HEALTHCARE INC | 8 | 2010–2011 |
| BAYLOR COLLEGE OF MEDICINE | 7 | 2012–2014 |
| DAVITA INC. | 7 | 2010–2011 |
| ENTERPRISE HOLDINGS | 7 | 2011–2013 |
| LOCKHEED MARTIN CORPORATION | 7 | 2010–2011 |
| AMGEN | 6 | 2010–2014 |
| BRISTOL-MYERS SQUIBB | 6 | 2010–2011 |
| HENRY SCHEIN INC | 6 | 2011 |
| SALLIE MAE, INC. | 6 | 2010–2012 |
| CUBIST PHARMACEUTICALS, INC. | 5 | 2010–2011 |
| SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT INC | 5 | 2010–2011 |
| GENZYME | 4 | 2013–2014 |
| HEMISPHERX BIOPHARMA, INC. | 4 | 2013 |
| OPENCONNECT SYSTEMS INCORPORATED | 4 | 2010 |
| ASS'N OF PRIVATE SECTOR COLLEGES AND UNIVERSITIES (FKA CAREER COLLEGE ASS'N) | 3 | 2010–2011 |
| CAREER EDUCATION CORPORATION | 3 | 2010–2011 |
| GENERAL MOTORS COMPANY | 3 | 2010–2011 |
| JAB DISTRIBUTERS, LLC (D/B/A PROTECT-A-BED) | 3 | 2010–2011 |
| NOVO NORDISK, INC. | 3 | 2010–2011 |
| HEADWATERS, INC. | 2 | 2011–2012 |
| MONSTER ENERGY COMPANY | 2 | 2012–2013 |
| PURESTREAM TECHNOLOGY, INC. | 2 | 2010 |
| ROCKSTAR, INC. | 2 | 2013 |
| SIEGEL & GALE LLC | 2 | 2010–2011 |
| THE OASIS INSTITUTE | 2 | 2010–2011 |
| BOEING | 1 | 2012 |
| BP AMERICA, INC. | 1 | 2010 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1 | 2013 |
| COALTION FOR AFFORDABLE SOLAR ENERGY | 1 | 2012 |
| DAC MANAGEMENT, LLC | 1 | 2013 |
| EISAI INC. | 1 | 2010 |
| EMD SERONO, INC. | 1 | 2011 |
| GOOGLE INC. | 1 | 2010 |
| INSTITUTE OF SCRAP RECYCLING INDUSTRIES, INC. | 1 | 2012 |
| NATIONAL CONFECTIONERS ASSOCIATION | 1 | 2011 |
| ONTARIO TEACHERS' PENSION PLAN BOARD | 1 | 2013 |
| US AIRWAYS GROUP, INC. | 1 | 2012 |
Promoting Integrity in Medicare Act of 2013
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Keep Your Health Plan Act of 2013
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.R. 3541 / S. 1726, Obamacare Taxpayer Bailout Prevention Act.
Obamacare Taxpayer Bailout Prevention Act
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.R. 3541 / S. 1726, Obamacare Taxpayer Bailout Prevention Act.
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Protecting Access to Medicare Act of 2014
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: PODESTA GROUP, INC.
Center for Medicare and Medicaid Services proposed rules. H.R. 4302, Protecting Access to Medicare Act of 2014. Payment for home health services. Program integrity issues.
Medicare Part B drug reimbursement and coverage. Medicare and Medicaid reimbursement. H.R.4302, Protecting Access to Medicare Act of 2014
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.R. 3541 / S. 1726, Obamacare Taxpayer Bailout Prevention Act.
Obamacare Taxpayer Bailout Prevention Act
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.R. 3541 / S. 1726, Obamacare Taxpayer Bailout Prevention Act.
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Resident Physician Shortage Reduction Act of 2013
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Training Tomorrow's Doctors Today Act
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.
Training Tomorrow's Doctors Today Act
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H. J. Res. 59, Continuing Appropriations Resolution, 2014
Training Tomorrow's Doctors Today Act
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: PODESTA GROUP, INC.
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: PODESTA GROUP, INC.
Regulations affecting medical devices and cosmetics. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: PODESTA GROUP, INC.
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Promoting Integrity in Medicare Act of 2013
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H. J. Res. 59, Continuing Appropriations Resolution, 2014.
Keep Your Health Plan Act of 2013
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.J.Res. 59, Continuing Appropriations Resolution, 2014.
H.R. 527 / S. 783, Helium Stewardship Act of 2013.
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.J.Res. 59, Continuing Appropriations Resolution, 2014.
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL · Firm: PODESTA GROUP, INC.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.S. 1009, Chemical Safety Improvement Act.
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL · Firm: PODESTA GROUP, INC.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.S. 1009, Chemical Safety Improvement Act.
Chemical Safety Improvement Act
Client: AMERICAN CHEMISTRY COUNCIL · Firm: PODESTA GROUP, INC.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.S. 1009, Chemical Safety Improvement Act.
Resident Physician Shortage Reduction Act of 2013
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.
Resident Physician Shortage Reduction Act of 2013
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.
Resident Physician Shortage Reduction Act of 2013
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H. J. Res. 59, Continuing Appropriations Resolution, 2014
H.R. 527 / S. 783, Helium Stewardship Act of 2013.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Drug Supply Chain Security Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: PODESTA GROUP, INC.
Regulations affecting medical devices and cosmetics. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Drug Supply Chain Security Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: PODESTA GROUP, INC.
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Patient Protection and Affordable Care Act (implementation). S. 957, Drug Supply Chain Security Act. S. 959, Pharmaceutical Quality, Security, and Accountability Act. FDASIA implementation.Sustainable Growth Rate repeal and reform proposals.
Drug Supply Chain Security Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: PODESTA GROUP, INC.
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Pharmaceutical Quality, Security, and Accountability Act
Client: GENZYME · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act (implementation). S. 957, Drug Supply Chain Security Act. S. 959, Pharmaceutical Quality, Security, and Accountability Act. FDASIA implementation.Sustainable Growth Rate repeal and reform proposals.
American Taxpayer Relief Act of 2012
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. H.R. 8, American Taxpayer Relief Act.
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: PODESTA GROUP, INC.
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H. J. Res. 59, Continuing Appropriations Resolution, 2014
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: PODESTA GROUP, INC.
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues. H. J. Res. 59, Continuing Appropriations Resolution, 2014.
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.J.Res. 59, Continuing Appropriations Resolution, 2014.
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Medicare reimbursement related to provisions in the Affordable Care Act and federal budget negotiations. Medicare clinical laboratory fee schedule updates. Physician self-referral relating to anatomic pathology (no specific bills). H.J.Res 59, Continuing Appropriations Resolution, 2014.
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H. J. Res. 59, Continuing Appropriations Resolution, 2014.
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: BLUE SHIELD OF CALIFORNIA · Firm: PODESTA GROUP, INC.
Legislation and regulations affecting health plans. H.R. 1370, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
New Alternative Transportation to Give Americans Solutions Act of 2011
Client: AMERICAN CHEMISTRY COUNCIL · Firm: PODESTA GROUP, INC.
H.R. 1380 / S. 1863, New Alternative Transportation to Give Americans Solutions Act of 2011. H.R. 4348 / S. 1813, MAP-21 (transportation reauthorization).
Health IT issues; waste, fraud, and abuse issues. H.R. 173, Medicare Fraud Prevention Act of 2011 H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 S. 1251, Medicare and Medicaid FAST Act of 2011 H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Coal Residuals Reuse and Management Act
Client: HEADWATERS, INC. · Firm: PODESTA GROUP, INC.
EPA fly ash rulemaking. H.R. 2273 / S. 1571, Coal Residuals Reuse and Management Act. H.R. 4348 / S. 1813 MAP-21 (transportation reauthorization)
Responsible Electronics Recycling Act
Client: INSTITUTE OF SCRAP RECYCLING INDUSTRIES · Firm: PODESTA GROUP, INC.
Electronics and plastics recycling issues. Resource Conservation & Recovery Act issues. Toxic Substance Control Act reauthorization. H.R. 2284 / S. 1270, Responsible Electronics Recycling Act.
H.R. 3179, Marketplace Equity Act of 2011. S. 1832, Marketplace Fairness Act. Corporate tax reform (no bills).
H.R. 3179, Marketplace Equity Act of 2011. S. 1832, Marketplace Fairness Act. Corporate tax reform (no bills).
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Guidance Accountability and Transparency Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Oversight of laboratory services and genetic information and testing. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. Patient Protection and Affordable Care Act implementation.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Oversight of laboratory services and genetic information and testing. Policies regarding prescription drug monitoring (no specific bills). H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: PODESTA GROUP, INC.
Oversight of laboratory services and genetic information and testing. Policies regarding prescription drug monitoring (no specific bills). H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. Patient Protection and Affordable Care Act implementation.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Food and Drug Administration Mission Reform Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
Keeping America Competitive Through Harmonization Act of 2011
Client: COVIDIEN · Firm: PODESTA GROUP, INC.
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Regulations affecting medical devices, pharmaceuticals and cosmetics.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE SHIELD OF CALIFORNIA via PODESTA GROUP, INC.
2014 · first_quarter · 1T
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.R. 3541 / S. 1726, Obamacare Taxpayer Bailout Prevention Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via PODESTA GROUP, INC.
2014 · first_quarter · Q1
Issues related to medical schools and health research. Public awareness of advances in genomic medicine. Neglected tropical diseases. Space biomedical research.
Agricultural Research Service administrative charges.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2014 · first_quarter · 1T
Center for Medicare and Medicaid Services proposed rules. H.R. 4302, Protecting Access to Medicare Act of 2014. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2014 · first_quarter · 1T
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Veterans' employment training and recruitment programs.
Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation. Policies regarding drugs of abuse testing.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
ST. JUDE MEDICAL, INC. via PODESTA GROUP, INC.
2014 · first_quarter · 1T
Patient Protection and Affordable Care Act implementation. Oversight and regulation of medical devices.
Filing targets: SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2014 · first_quarter · 1T
FDA regulation of antibiotics, plasma derivatives, and rare diseases. Insurance and Medicaid coverage of rare disease therapies and essential health benefits.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via PODESTA GROUP, INC.
2014 · first_quarter · Q1
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) via PODESTA GROUP, INC.
2014 · first_quarter · 1T
Issues related to healthcare industry management. Patient Protection and Affordable Care Act (implementation).
Filing targets: Health & Human Services, Dept of (HHS)
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2014 · first_quarter · Q1
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2014 · first_quarter · Q1
Medicare Part B drug reimbursement and coverage. Medicare and Medicaid reimbursement. H.R.4302, Protecting Access to Medicare Act of 2014
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2013 · first_quarter · 1A
Health IT issues. Waste, fraud, and abuse issues.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
BLUE SHIELD OF CALIFORNIA via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. H.R. 3350, Keep Your Health Plan Act of 2013. H.J.Res. 59, Continuing Appropriations Resolution, 2014.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Regulations affecting medical devices and cosmetics. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Issues related to healthcare industry management. Patient Protection and Affordable Care Act (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2013 · fourth_quarter · 4A
Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation. Policies regarding drugs of abuse testing.
Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills). Self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914). Patient Protection and Affordable Care Act implementation. H. J. Res. 59, Continuing Appropriations Resolution, 2014.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
FDA regulation of antibiotics, plasma derivatives, and rare diseases. Insurance and Medicaid coverage of rare disease therapies and essential health benefits. Orphan drug tax. Drug supply chain security.Sustainable Growth Rate repeal and reform proposals. Patient-Centered Outcome Research Institute (PCORI). Rare disease panels.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE MEDICAL, INC. via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
International trade issues affecting medical devices.
Patient Protection and Affordable Care Act implementation. Oversight and regulation of medical devices.
Filing targets: SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Medicare reimbursement related to provisions in the Affordable Care Act and federal budget negotiations. Medicare clinical laboratory fee schedule updates. Physician self-referral relating to anatomic pathology (no specific bills). H.J.Res 59, Continuing Appropriations Resolution, 2014.
Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation. Policies regarding drugs of abuse testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues. H. J. Res. 59, Continuing Appropriations Resolution, 2014.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ONTARIO TEACHERS' PENSION PLAN BOARD via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Foreign Investment in Real Property Tax Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CANADA PENSION PLAN INVESTMENT BOARD via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Foreign Investment in Real Property Tax Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GENZYME via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (implementation). S. 957, Drug Supply Chain Security Act. S. 959, Pharmaceutical Quality, Security, and Accountability Act. FDASIA implementation.Sustainable Growth Rate repeal and reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Issues related to medical schools and health research. Healthcare budget sequestration. Neglected tropical diseases. Public awareness of advances in genomic medicine.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2013 · fourth_quarter · 4T
Rail safety and positive train control.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.S. 1009, Chemical Safety Improvement Act.
Corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via PODESTA GROUP, INC.
2013 · fourth_quarter · Q4
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.H. J. Res. 59, Continuing Appropriations Resolution, 2014
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Q4
Medicare Part B drug reimbursement and coverage. Sustainable growth rate repeal and reform proposals. Medicare and medicaid reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAC MANAGEMENT, LLC via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Corporate tax reform. Tax resolution procedures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Issues related to healthcare industry management. Patient Protection and Affordable Care Act (implementation).
Filing targets: Health & Human Services, Dept of (HHS)
HEMISPHERX BIOPHARMA, INC. via PODESTA GROUP, INC.
2013 · third_quarter · Q3
FDA regulation of therapies for chronic fatigue syndrome. Biodefense and pandemic preparedness issues.
Filing targets: Executive Office of the President (EOP)
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE
GENZYME via PODESTA GROUP, INC.
2013 · third_quarter · Q3
340B issues. Patient Protection and Affordable Care Act (implementation). Drug supply chain security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE SHIELD OF CALIFORNIA via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Issues related to medical schools and health research. Healthcare budget sequestration. Neglected tropical diseases. Funding for traumatic brain research.Public awareness of advances in genomic medicine.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Smithsonian Institution
2013 · third_quarter · Q3
Medicare Part B drug reimbursement and coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.S. 1009, Chemical Safety Improvement Act.
Corporate tax reform.
Filing targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2013 · third_quarter · Q3
Medicare reimbursement related to provisions in the Affordable Care Act and federal budget negotiations. Medicare clinical laboratory fee schedule updates. Physician self-referral relating to anatomic pathology (no specific bills).
Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation. Policies regarding drugs of abuse testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE MEDICAL, INC. via PODESTA GROUP, INC.
2013 · third_quarter · Q3
International trade issues affecting medical devices.
Patient Protection and Affordable Care Act implementation. Oversight and regulation of medical devices.
H.R. 527 / S. 783, Helium Stewardship Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2013 · third_quarter · Q3
FDA regulation of antibiotics, plasma derivatives, and rare diseases. Insurance and Medicaid coverage of rare disease therapies and essential health benefits. Orphan drug tax. Drug supply chain security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2013 · second_quarter · 2A
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2013 · second_quarter · 2A
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2013 · second_quarter · Q2
FDA regulation of antibiotics, plasma derivatives, and rare diseases. Insurance coverage of rare disease therapies and essential health benefits. Orphan drug tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE MEDICAL, INC. via PODESTA GROUP, INC.
2013 · second_quarter · Q2
International trade issues affecting medical devices.
Patient Protection and Affordable Care Act implementation. Oversight and regulation of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE
RELX INC via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Health IT issues. Waste, fraud, and abuse issues.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation. Policies regarding drugs of abuse testing.
Medicare reimbursement related to provisions in the Affordable Care Act and federal budget negotiations. Physician self-referral relating to anatomic pathology (no specific bills).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMISPHERX BIOPHARMA, INC. via PODESTA GROUP, INC.
2013 · second_quarter · Q2
FDA regulation of therapies for chronic fatigue syndrome. Biodefense and pandemic preparedness issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENZYME via PODESTA GROUP, INC.
2013 · second_quarter · Q2
340B issues. Patient Protection and Affordable Care Act (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Issues related to healthcare industry management. Patient Protection and Affordable Care Act (implementation).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Issues related to the coverage of spiritual care. H.R. 1814 / S. 862, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE
BLUE SHIELD OF CALIFORNIA via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Legislation and regulations affecting health plans. H.R. 763, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Issues related to medical schools and health research. Healthcare budget sequestration. Neglected tropical diseases. Funding for traumatic brain research.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · second_quarter · Q2
Medicare Part B drug reimbursement and coverage.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Corporate tax reform.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.S. 1009, Chemical Safety Improvement Act.
Filing targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via PODESTA GROUP, INC.
2013 · second_quarter · Q2
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. S. 577, Resident Physician Shortage Reduction Act of 2013. H.R. 1201, Training Tomorrow's Doctors Today Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Health IT issues. Waste, fraud, and abuse issues.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE
JOHNSON & JOHNSON SERVICES, INC. via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Regulations affecting medical devices and cosmetics. Pharmaceutical supply chain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMISPHERX BIOPHARMA, INC. via PODESTA GROUP, INC.
2013 · first_quarter · Q1
FDA regulation of therapies for chronic fatigue syndrome.
Filing targets: Food & Drug Administration (FDA), SENATE
COVIDIEN via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Patient Protection and Affordable Care Act implementation. Issues related to nuclear medicine and isotopes production. FDA approval process/510(k) legislation. Medical device tax legislation.
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Issues related to healthcare industry management. Patient Protection and Affordable Care Act (implementation).
Filing targets: Health & Human Services, Dept of (HHS), SENATE
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Issues related to the coverage of spiritual care.
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2013 · first_quarter · Q1
FDA regulation of antibiotics, plasma derivatives, and rare diseases. Insurance coverage of rare disease therapies and essential health benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE SHIELD OF CALIFORNIA via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Legislation and regulations affecting health plans.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. Consumer Product Safety Improvement Act of 2002 (implementation). Toxic Substances Control Act reform. Chemical facility anti-terrorism standards.
Rail safety and proper train control.
Corporate tax reform.
Filing targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE MEDICAL, INC. via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Patient Protection and Affordable Care Act implementation. Oversight and regulation of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE
ROCKSTAR, INC. via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Legislation and oversight regarding energy drinks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation.
Medicare reimbursement related to provisions in the Affordable Care Act and federal budget negotiations. Physician self-referral relating to anatomic pathology (no specific bills).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. H.R. 8, American Taxpayer Relief Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MONSTER ENERGY COMPANY via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Legislation and oversight regarding energy drinks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENTERPRISE HOLDINGS via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Rental car safety issues. Federal Odometer Act.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Comptroller of the Currency (OCC), SENATE
BAYLOR COLLEGE OF MEDICINE via PODESTA GROUP, INC.
2013 · first_quarter · Q1
Issues related to medical schools and health research. Healthcare budget sequestration. Neglected tropical diseases. Funding for traumatic brain research.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROCKSTAR, INC. via PODESTA GROUP, INC.
2013 · first_quarter · RR
Legislation and oversight regarding energy drinks.
HEMISPHERX BIOPHARMA, INC. via PODESTA GROUP, INC.
2013 · first_quarter · RR
FDA regulation of therapies for chronic fatigue syndrome.
SALLIE MAE, INC. via PODESTA GROUP, INC.
2012 · first_quarter · 1A
H. Con. Res. 112, Establishing the budget for the United States Government for fiscal year 2013 and setting forth appropriate budgetary levels for fiscal years 2014 through 2022. FY 2013 President's Budget.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
WAL-MART via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
H.R. 3179, Marketplace Equity Act of 2011. S. 1832, Marketplace Fairness Act. Corporate tax reform (no bills).
Filing targets: Council of Economic Advisers (CEA), HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Corporate tax reform.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. H.R. 5855 / S. 3216, Department of Homeland Security Appropriations Act, 2013. S. 847, Safe Chemicals Act of 2011. Consumer Product Safety Improvement Act of 2002 (implementation).
Filing targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MONSTER ENERGY COMPANY via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Legislation and oversight regarding energy drinks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Issues related to medical schools and health research. Healthcare budget sequestration. Neglected tropical diseases.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS)
WAL-MART via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
H.R. 3179, Marketplace Equity Act of 2011. S. 1832, Marketplace Fairness Act. Corporate tax reform (no bills).
Filing targets: Council of Economic Advisers (CEA), HOUSE OF REPRESENTATIVES, SENATE
VIROPHARMA INCORPORATED via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. FDA regulation of antibiotics, plasma derivatives, and rare diseases. Coverage of rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES
ST. JUDE MEDICAL, INC. via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Federal Helium Reserve
Patient Protection and Affordable Care Act implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. Oversight of medical devices.
Filing targets: SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Regulations affecting medical devices. Pharmaceutical supply chain management. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. CMS coverage for transcutaneous electrical nerve stimulation for lower back pain
CONIFER REVENUE CYCLE SOLUTIONS, LLC (A SUBSIDIARY OF TENET HEALTHCARE CORP.) via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Issues related to healthcare industry management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care. H.R. 6597 / S. 3695, EACH Act.
Issues related to the coverage of spiritual care. H.R. 6597 / S. 3695, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Corporate tax reform.
Legislative and regulatory issues related to EPA and NIH chemical reports and assessments. H.R. 5855 / S. 3216, Department of Homeland Security Appropriations Act, 2013. S. 847, Safe Chemicals Act of 2011. Consumer Product Safety Improvement Act of 2002 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Medicare funding for graduate medical education. Medicare reimbursement for hospital outpatient services. Federal budget issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE